Sundar S - Search Results

1

Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.

Pérez-Victoria FJ, Sánchez-Cañete MP, Seifert K, Croft SL, Sundar S, Castanys S, Gamarro F. Pérez-Victoria FJ, et al. Among authors: sundar s. Drug Resist Updat. 2006 Feb-Apr;9(1-2):26-39. doi: 10.1016/j.drup.2006.04.001. Drug Resist Updat. 2006. PMID: 16814199 Review.

2

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD. Guerin PJ, et al. Among authors: sundar s. Lancet Infect Dis. 2002 Aug;2(8):494-501. doi: 10.1016/s1473-3099(02)00347-x. Lancet Infect Dis. 2002. PMID: 12150849 Review.

3

Leishmaniasis: new approaches to disease control.

Davies CR, Kaye P, Croft SL, Sundar S. Davies CR, et al. Among authors: sundar s. BMJ. 2003 Feb 15;326(7385):377-82. doi: 10.1136/bmj.326.7385.377. BMJ. 2003. PMID: 12586674 Free PMC article. Review. No abstract available.

4

Drug resistance in leishmaniasis.

Croft SL, Sundar S, Fairlamb AH. Croft SL, et al. Among authors: sundar s. Clin Microbiol Rev. 2006 Jan;19(1):111-26. doi: 10.1128/CMR.19.1.111-126.2006. Clin Microbiol Rev. 2006. PMID: 16418526 Free PMC article. Review.

5

Miltefosine: issues to be addressed in the future.

Berman J, Bryceson AD, Croft S, Engel J, Gutteridge W, Karbwang J, Sindermann H, Soto J, Sundar S, Urbina JA. Berman J, et al. Among authors: sundar s. Trans R Soc Trop Med Hyg. 2006 Dec;100 Suppl 1:S41-4. doi: 10.1016/j.trstmh.2006.02.009. Epub 2006 Jun 5. Trans R Soc Trop Med Hyg. 2006. PMID: 16750231 Review.

6

Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance.

Ashutosh, Garg M, Sundar S, Duncan R, Nakhasi HL, Goyal N. Ashutosh, et al. Among authors: sundar s. Antimicrob Agents Chemother. 2012 Jan;56(1):518-25. doi: 10.1128/AAC.00736-11. Epub 2011 Nov 7. Antimicrob Agents Chemother. 2012. PMID: 22064540 Free PMC article.

7

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.

Bhandari V, Kulshrestha A, Deep DK, Stark O, Prajapati VK, Ramesh V, Sundar S, Schonian G, Dujardin JC, Salotra P. Bhandari V, et al. Among authors: sundar s. PLoS Negl Trop Dis. 2012;6(5):e1657. doi: 10.1371/journal.pntd.0001657. Epub 2012 May 22. PLoS Negl Trop Dis. 2012. PMID: 22629478 Free PMC article.

8

Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani.

Kulshrestha A, Bhandari V, Mukhopadhyay R, Ramesh V, Sundar S, Maes L, Dujardin JC, Roy S, Salotra P. Kulshrestha A, et al. Among authors: sundar s. Parasitol Res. 2013 Feb;112(2):825-8. doi: 10.1007/s00436-012-3212-3. Epub 2012 Dec 13. Parasitol Res. 2013. PMID: 23239091

9

Case study for a vaccine against leishmaniasis.

Alvar J, Croft SL, Kaye P, Khamesipour A, Sundar S, Reed SG. Alvar J, et al. Among authors: sundar s. Vaccine. 2013 Apr 18;31 Suppl 2:B244-9. doi: 10.1016/j.vaccine.2012.11.080. Vaccine. 2013. PMID: 23598489 Review.

10

In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis.

Prajapati VK, Sharma S, Rai M, Ostyn B, Salotra P, Vanaerschot M, Dujardin JC, Sundar S. Prajapati VK, et al. Among authors: sundar s. Am J Trop Med Hyg. 2013 Oct;89(4):750-4. doi: 10.4269/ajtmh.13-0096. Epub 2013 Aug 26. Am J Trop Med Hyg. 2013. PMID: 23980130 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,114 results

Search Page